Photocure ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Photocure ASA with three other
companies in this sector in NORWAY :
Vistin Pharma ASA
sales of 227.19 million Norwegian Kroner [US$25.05 million]
(127.12 million Norwegian Kroner [US$14.02 million]
of which 100%
was Vitamin K2/MenaQ7), and
(83.94 million Norwegian Kroner [US$9.26 million]
During the year ended December of 2019, sales at
Photocure ASA were NOK 281.56 million (US$31.05 million).
increase of 55.1%
versus 2018, when the company's sales were NOK 181.51 million.
This was the fifth consecutive year of sales increases at Photocure ASA
(and since 2014, sales have increased a total of 118%).
Sales of Hexvix/cysview Own Sales saw an increase
32.7% in 2019, from
NOK 110.73 million to NOK 146.88 million.
Not all segments of Photocure ASA experienced an increase in sales in 2019:
sales of Other Sales fell 86.6% to NOK 694,000.00 .
(However, this segment's sales were only a very small portion of the company's overall sales).